FDA Inspection 1264024 — Sanofi Vaccines Canada Ltd
The FDA completed an inspection of Sanofi Vaccines Canada Ltd on Mar 18, 2025 in North York. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Biologics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Mar 18, 2025
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- North York (Canada)